Poly Lactic-Co-Glycolic Acid- (PLGA-) Loaded Nanoformulation of Cisplatin as a Therapeutic Approach for Breast Cancers

<div>Annexin-V/PI staining to analyze apoptosis/necrosis in MCF-7 cells. Time-dependent study (12 and 24 h) after treatment of cells with 23 <i>μ</i>g/mL of PLGA-cisplatin. (a) Untreated cells. (b) Differences in the percentage of cell death in the treated cells for 12 h. (c) Differences in the percentage of cell death in treated cells for 24 h.</div>

Oxidative Medicine and Cellular Longevity

fig5

Figure 5

Figure 5: Poly Lactic-Co-Glycolic Acid- (PLGA-) Loaded Nanoformulation of Cisplatin as a Therapeutic Approach for Breast Cancers 